CNCE

Concert Pharmaceuticals, Inc.
CNCE

Overview Fund Activity
Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

97 hedge funds and large institutions have $154M invested in Concert Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
–
Holders Change %
0%
% of All Funds
2.59%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
11
Increased
39
Reduced
29
Closed
10
Calls
$17K
Puts
$24K
Net Calls
-$7K
Net Calls Change
-$22K

Top Buyers

1
ISL
1
Ingalls & Snyder LLC
New York
$7.01M
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$3.09M
3
NI
3
Numeric Investors
Massachusetts
$6.95M
4
GCP
4
GSA Capital Partners
United Kingdom
$1.69M
5
DCM
5
DAFNA Capital Management
California
$752K

Top Sellers

1
SAM
1
Senzar Asset Management
New York
$8.99M
2
Millennium Management
2
Millennium Management
New York
$3.19M
3
EI
3
EAM Investors
California
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$1.73M
5
TC
5
TFS Capital
Pennsylvania
$207K
Name Holding Trade Value Shares
Change 		Shares
Change %
DC
101
Deere & Company
Illinois
– -$505K -36,951 Closed
Two Sigma Investments
102
Two Sigma Investments
New York
– -$428K -31,340 Closed
WSA
103
Wall Street Associates
California
– -$318K -23,300 Closed
DTL
104
Dynamic Technology Lab
Singapore
– -$170K -12,466 Closed
DekaBank Deutsche Girozentrale
105
DekaBank Deutsche Girozentrale
Germany
– -$127K -9,600 Closed
New York State Teachers Retirement System (NYSTRS)
106
New York State Teachers Retirement System (NYSTRS)
New York
– -$3K -200 Closed
JFA
107
JNBA Financial Advisors
Minnesota
– -$1K -75 Closed
1 2 3 4
5